Forest Laboratories Inc.

NYS : FRX
Pharmaceuticals
New York NY
2013 Revenue (US$ Millions)$3,126
2012 Revenue (US$ Millions)$4,586
Revenue Growth (%)-31.83%
Net Income (US$ Millions)($32)
Common Shares Outstanding (Millions)$267
Earnings Per Share (US$)($0.12)
Price To Earnings Ratio38.15
Total Equity (US$ Millions)$5,745
Profit Margin (%)-1.03%
Return On Equity (%)-0.57%
Long Term Debt (US$ Millions)N/A
Debt To Equity Ratio (%)N/A
Market Capitalization (US$ Millions)$10,138
Total Assets (US$ Millions)$7,630
Return on Assets (%)-0.43
Current Assets (US$ Millions)$2,948
Inventories (US$ Millions)$394
Current Liabilities (US$ Millions)$998
Cost of Goods Sold (US$ Millions)$649
Asset Turnover0.41
Inventory Turnover1.88
ExchangeNYS